⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26367110 | 0.78 | TDP1 (0.32) | — | |
| SCHEMBL24816608 | 0.76 | — | — | |
| SCHEMBL13917745 | 0.73 | TDP1 (0.32) | — | |
| SCHEMBL11232764 | 0.73 | — | — | |
| SCHEMBL221789 | 0.70 | TET2 (0.43) | — | |
| SCHEMBL8034524 | 0.69 | — | — | |
| SCHEMBL24380469 | 0.68 | — | — | |
| SCHEMBL28382905 | 0.67 | — | — | |
| SCHEMBL24799640 | 0.65 | — | — | |
| SCHEMBL9413479 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303509-A1 | SULFONAMIDO DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS | NIKANG THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |